Navigation Links
Vion Pharmaceuticals Presents Clinical Data from a Phase II Trial,of Cloretazine (VNP40101M) in Elderly AML Patients with Unfavorable,Cytogenetics at EHA Meeting

t to certain risk factors which may cause Vion's plans to differ or results to vary from those expected, including Vion's potential inability to obtain regulatory approval for its products, delayed or unfavorable results of drug trials, the possibility that favorable results of earlier preclinical studies or clinical trials are not predictive of safety and efficacy results in later clinical trials, the need for additional research and testing, the potential inability to secure external sources of funding to continue operations, the inability to access capital and funding on favorable terms, continued operating losses and the inability to continue operations as a result, and a variety of other risks set forth from time to time in Vion's filings with the Securities and Exchange Commission, including but not limited to the risks attendant to the forward-looking statements included under Item 1A, "Risk Factors" in Vion's Annual Report on Form 10-K for the year ended December 31, 2006. In particular, there can be no assurance as to the results of any of the Company's clinical trials, that any of these trials will continue to full accrual, or that any of these trials will not be discontinued, modified, delayed or ceased altogether. Except in special circumstances in which a duty to update arises under law when prior disclosure becomes materially misleading in light of subsequent events, Vion does not intend to update any of these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

    COMPANY CONTACT:  Vion Pharmaceuticals, Inc.

                      Alan Kessman, Chief Executive Officer

                      Howard B. Johnson, President & CFO

                      (203) 498-4210 phone

CONTACT: Alan Kessman, Chief Executive Officer, or Howard B. Johnson,President & CFO, both of Vion Pharmaceuticals, Inc., +1-203-498-4210

Web site: '"/>




Page: 1 2 3 4

Related medicine technology :

1. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
2. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
4. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
5. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
6. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
7. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
8. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
9. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
10. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
11. Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4 Inhibitor, ARI-2243, at the ADA
Post Your Comments:
(Date:11/21/2014)... 2014 Depomed, Inc. (NASDAQ: DEPO ) today ... th Annual Healthcare Conference in New York City ... is scheduled for 8:00 am EST (5:00 am PST) on Tuesday ... can be accessed via the Investor Relations page of the Depomed ... be archived for 30 days on the company,s website. ...
(Date:11/21/2014)... Nov. 20, 2014   Wellcentive , the ... for healthcare organizations, announced today being named one ... Intel Innovation Award .  Sponsored by Intel, the ... its fourth year, recognizes companies developing leading-edge technology ... delivery processes. Wellcentive,s Mason ...
(Date:11/18/2014)... LAWRENCE, Mass. , Nov. 18, 2014 /PRNewswire/ ... NXTM ), a leading manufacturer of innovative ... its new  Streamline® Express dialyzer for the ... blood tubing set, which is designed to reduce ... and to reduce the number of touch point ...
Breaking Medicine Technology:Depomed To Present At Piper Jaffray 26th Annual Healthcare Conference 2Wellcentive Named Finalist for 2014 Intel Innovation Award 2Wellcentive Named Finalist for 2014 Intel Innovation Award 3NxStage Launches New Streamline Express Dialyzer With Pre-attached Blood Tubing Set 2
(Date:11/22/2014)... Forbes Living TV and featured ... that Ashley Lombardo and friend Candy Sherman are the ... Lombardo entered friend Candy Sherman to receive a generous ... her friend is courageously battling lung cancer and raising ... medical bills piling up and the constant struggle to ...
(Date:11/22/2014)... (PRWEB) November 22, 2014 A ... was announced today which safely detects and identifies ... frequency radio waves. Developed by RHT SpectraSafe, the ... hosts broad applications in other areas including medical, ... security. , Using high frequency radio waves that ...
(Date:11/22/2014)... Wright & Schulte LLC reports that six ... been scheduled between October 2016 and April 2017 in ... District Judge Matthew F. Kennelly, who is overseeing the ... on November 6, 2014 that outlined the trial schedule ... and other activities in preparation for the bellwether jury ...
(Date:11/22/2014)... News) -- Many young people consider hookahs a hip ... finds fumes from the water pipes contain the toxin ... risk for leukemia in prior research, according to a ... Cancer Epidemiology, Biomarkers & Prevention . "In contrast ... a safe alternative to smoking other forms of tobacco," ...
(Date:11/22/2014)... widely used heart drug digoxin is associated with increased ... the heart rhythm disorder atrial fibrillation but no evidence ... fibrillation is a common form of irregular heartbeat that ... stroke among older Americans. Digoxin has been used for ... the authors of the new study said, and many ...
Breaking Medicine News(10 mins):Health News:Forbes Living TV Announces Winner of Thanksgiving #PayItForward Contest 2Health News:RHT SpectraSafe announces a Radical New Airport Security Technology that Is More Effective, Less Invasive 2Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 2Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 3Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 4Health News:Hookahs Deliver Toxic Benzene in Every Puff, Study Shows 2Health News:Treating Irregular Heartbeat With Digoxin May Come With Risks 2Health News:Treating Irregular Heartbeat With Digoxin May Come With Risks 3
... a link between air pollution and heart attacks. ... and Haemostasis looks specifically at airborne particulate matter ... coal and also from forest fires, reports science ... and long-term exposure to these particulates is associated ...
... already a huge health problem in Asia that is getting ... years (by 2050), one out of every two fractures in ... figures projected above, it would be sensible for men and ... of their lifestyle. ,Osteoporosis, in which the bones ...
... a study in the September issue of Archives of ... for poor health and mental conditions//. ,Besides basic ... and understand numerical information such as that on prescription ... information such as appointment slips, to be able to ...
... face more than twice the risk of developing breast ... Netherlands examined the relation between handedness// and incidence of ... born between 1932 and 1941, reports science portal EurekAlert. ... such as social and economic status, smoking habits, family ...
... presenting a paper at the 109th Annual Meeting & ... held September 25-28, 2005 on the impact of age ... adult patients with inflammatory paranasal sinus disease at a ... disease is used to encompass CRS, CRS with polyposis, ...
... in the plant kingdom among pulses. Besides providing the body ... to have numerous other health benefits//. It is nicknamed as ... of diabetes, and improve overall health. ,Sometime back ... the Post menopausal period but now men have a reason ...
Cached Medicine News:Health News:Beauty Queens Urge On The Importance Of Maintaining Bone Integrity 2Health News:Age Can Changes Symptoms Of Sinusitis 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: